News

April 16, 2020April 16, 2020

Concure’s New $2.5M Funding to Boost Patient Access to its Radioactive Seed Treatment

News

Concure Oncology plans to use $2.5 million in new funding to help make its targeted radiation treatment option increasingly available to early-stage breast cancer patients. Specifically, the funding round is expected ... Read more

April 9, 2020April 9, 2020

Positive Results Support Early Halt to Phase 3 Trial Testing Sacituzumab Govitecan for TNBC

News

Immunomedics has halted its Phase 3 confirmatory trial of sacituzumab govitecan, due to strong evidence of its ability to delay disease progression in patients with advanced triple-negative breast cancer (TNBC). ... Read more

April 2, 2020April 2, 2020

CytoDyn Seeks Preliminary FDA Meeting on Leronlimab’s Breakthrough Therapy Status

News

After a recommendation from the U.S. Food and Drug Administration (FDA), CytoDyn is planning to ask the regulatory agency for a preliminary meeting to discuss the granting of breakthrough therapy status ... Read more

March 26, 2020March 26, 2020

Tumor Suppressor Neurofibromin Interacts with Estrogen Receptor, Revealing Potential Combo Breast Cancer Therapy

News

A tumor suppressor protein called neurofibromin, known to block the cancer-inducing Ras pathway, also was found to interact directly with the estrogen receptor (ER) with mutations in this protein leading ... Read more

March 23, 2020March 23, 2020

Komen Suggests Delaying Routine Mammograms During COVID-19 Outbreak

News

To help minimize the threat of COVID-19 to themselves and others, healthy women at average risk should postpone breast cancer screening until later this year, Susan G. Komen recommends. However, ... Read more

March 20, 2020March 20, 2020

Herzuma, Biosimilar to Herceptin, Available in US for HER2-positive Breast Cancers

News

Herzuma, a biosimilar to Genentech‘s Herceptin (trastuzumab), is now available in the U.S. for the same indications as the reference therapy, including for the treatment of HER2-positive breast cancers and stomach cancers. The ... Read more

March 18, 2020March 18, 2020

Fewer False-positive Mammograms May Need Human-Computer Mix

News

Artificial intelligence (AI) could be combined with radiologist assessments to improve the accuracy of breast cancer screenings, a study suggests. The study, “Evaluation of Combined Artificial Intelligence and Radiologist Assessment ... Read more

March 16, 2020March 23, 2020

Tumor Mutations May Help Predict Patients Best Suited to Pre-surgery Chemotherapy

News

Researchers identified mutations in breast cancer samples that may help predict which patients have the best chances of success from pre-surgical, or neoadjuvant, chemotherapy, and which may need an alternative ... Read more

March 13, 2020March 13, 2020

Platinum Chemo No Better than Standard in BRCA-mutated Early BC, Trial Finds

News

Women with newly diagnosed breast cancer who carry a mutation in their BRCA genes may continue to receive the standard pre-surgery chemotherapy regimen used for other breast cancer patients, according ... Read more

March 11, 2020March 11, 2020

Certain Inhaled Anesthetics May Promote Breast Cancer Spread, Mouse Study Suggests

News

The use of certain inhaled anesthetics during breast cancer surgery may increase the risk of cancer spreading in the body, a new study done in mice suggests. The study, “Distinct ... Read more